Literature DB >> 23921277

Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients.

Peter M C Klein Klouwenberg1, David S Y Ong, Lieuwe D J Bos, Friso M de Beer, Roosmarijn T M van Hooijdonk, Mischa A Huson, Marleen Straat, Lonneke A van Vught, Luuk Wieske, Janneke Horn, Marcus J Schultz, Tom van der Poll, Marc J M Bonten, Olaf L Cremer.   

Abstract

OBJECTIVES: Correct classification of the source of infection is important in observational and interventional studies of sepsis. Centers for Disease Control and Prevention criteria are most commonly used for this purpose, but the robustness of these definitions in critically ill patients is not known. We hypothesized that in a mixed ICU population, the performance of these criteria would be generally reduced and would vary among diagnostic subgroups.
DESIGN: Prospective cohort.
SETTING: Data were collected as part of a cohort of 1,214 critically ill patients admitted to two hospitals in The Netherlands between January 2011 and June 2011. PATIENTS: Eight observers assessed a random sample of 168 of 554 patients who had experienced at least one infectious episode in the ICU. Each patient was assessed by two randomly selected observers who independently scored the source of infection (by affected organ system or site), the plausibility of infection (rated as none, possible, probable, or definite), and the most likely causative pathogen. Assessments were based on a post hoc review of all available clinical, radiological, and microbiological evidence. The observed diagnostic agreement for source of infection was classified as partial (i.e., matching on organ system or site) or complete (i.e., matching on specific diagnostic terms), for plausibility as partial (2-point scale) or complete (4-point scale), and for causative pathogens as an approximate or exact pathogen match. Interobserver agreement was expressed as a concordant percentage and as a kappa statistic.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A total of 206 infectious episodes were observed. Agreement regarding the source of infection was 89% (183/206) and 69% (142/206) for a partial and complete diagnostic match, respectively. This resulted in a kappa of 0.85 (95% CI, 0.79-0.90). Agreement varied from 63% to 91% within major diagnostic categories and from 35% to 97% within specific diagnostic subgroups, with the lowest concordance observed in cases of ventilator-associated pneumonia. In the 142 episodes for which a complete match on source of infection was obtained, the interobserver agreement for plausibility of infection was 83% and 65% on a 2- and 4-point scale, respectively. For causative pathogen, agreement was 78% and 70% for an approximate and exact pathogen match, respectively.
CONCLUSIONS: Interobserver agreement for classifying sources of infection using Centers for Disease Control and Prevention criteria was excellent overall. However, full concordance on all aspects of the diagnosis between independent observers was rare for some types of infection, in particular for ventilator-associated pneumonia.

Entities:  

Mesh:

Year:  2013        PMID: 23921277     DOI: 10.1097/CCM.0b013e3182923712

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  62 in total

1.  Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU.

Authors:  Russell R Miller; Bert K Lopansri; John P Burke; Mitchell Levy; Steven Opal; Richard E Rothman; Franco R D'Alessio; Venkataramana K Sidhaye; Neil R Aggarwal; Robert Balk; Jared A Greenberg; Mark Yoder; Gourang Patel; Emily Gilbert; Majid Afshar; Jorge P Parada; Greg S Martin; Annette M Esper; Jordan A Kempker; Mangala Narasimhan; Adey Tsegaye; Stella Hahn; Paul Mayo; Tom van der Poll; Marcus J Schultz; Brendon P Scicluna; Peter Klein Klouwenberg; Antony Rapisarda; Therese A Seldon; Leo C McHugh; Thomas D Yager; Silvia Cermelli; Dayle Sampson; Victoria Rothwell; Richard Newman; Shruti Bhide; Brian A Fox; James T Kirk; Krupa Navalkar; Roy F Davis; Roslyn A Brandon; Richard B Brandon
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

2.  Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.

Authors:  Diederik G P J Geboers; Friso M de Beer; Anita M Tuip-de Boer; Tom van der Poll; Janneke Horn; Olaf L Cremer; Marc J M Bonten; David S Y Ong; Marcus J Schultz; Lieuwe D J Bos
Journal:  Intensive Care Med       Date:  2015-06-23       Impact factor: 17.440

3.  Kinase activity is impaired in neutrophils of sepsis patients.

Authors:  Arie J Hoogendijk; Lonneke A van Vught; Maryse A Wiewel; Gwenny M Fuhler; Hakima Belkasim-Bohoudi; Janneke Horn; Marcus J Schultz; Brendon P Scicluna; Maikel P Peppelenbosch; Cornelis van 't Veer; Alex F de Vos; Tom van der Poll
Journal:  Haematologica       Date:  2018-12-04       Impact factor: 9.941

4.  Ventilator-associated conditions versus ventilator-associated pneumonia: different by design.

Authors:  Michael Klompas
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

5.  Chronic healthcare expenditure in survivors of sepsis in the intensive care unit.

Authors:  Maria E Koster-Brouwer; Kirsten van de Groep; Wietze Pasma; Hugo M Smeets; Arjen J C Slooter; Dylan W de Lange; Diederik van Dijk; Tom van der Poll; Marc J M Bonten; Olaf L Cremer
Journal:  Intensive Care Med       Date:  2016-07-09       Impact factor: 17.440

6.  Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.

Authors:  Shih-Chin Cheng; Brendon P Scicluna; Rob J W Arts; Mark S Gresnigt; Ekta Lachmandas; Evangelos J Giamarellos-Bourboulis; Matthijs Kox; Ganesh R Manjeri; Jori A L Wagenaars; Olaf L Cremer; Jenneke Leentjens; Anne J van der Meer; Frank L van de Veerdonk; Marc J Bonten; Marcus J Schultz; Peter H G M Willems; Peter Pickkers; Leo A B Joosten; Tom van der Poll; Mihai G Netea
Journal:  Nat Immunol       Date:  2016-03-07       Impact factor: 25.606

7.  Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients.

Authors:  Robert P Dickson; Marcus J Schultz; Tom van der Poll; Laura R Schouten; Nicole R Falkowski; Jenna E Luth; Michael W Sjoding; Christopher A Brown; Rishi Chanderraj; Gary B Huffnagle; Lieuwe D J Bos
Journal:  Am J Respir Crit Care Med       Date:  2020-03-01       Impact factor: 21.405

Review 8.  Improving ventilator-associated event surveillance in the National Healthcare Safety Network and addressing knowledge gaps: update and review.

Authors:  Shelley S Magill; Barry Rhodes; Michael Klompas
Journal:  Curr Opin Infect Dis       Date:  2014-08       Impact factor: 4.915

9.  Associations between changes in oxygenation, dead space and driving pressure induced by the first prone position session and mortality in patients with acute respiratory distress syndrome.

Authors:  David M van Meenen; Jan-Paul Roozeman; Ary Serpa Neto; Paolo Pelosi; Marcelo Gama de Abreu; Janneke Horn; Olaf L Cremer; Frederique Paulus; Marcus J Schultz
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

10.  Macrolide therapy is associated with reduced mortality in acute respiratory distress syndrome (ARDS) patients.

Authors:  Fabienne D Simonis; Gianfranco de Iudicibus; Olaf L Cremer; David S Y Ong; Tom van der Poll; Lieuwe D Bos; Marcus J Schultz
Journal:  Ann Transl Med       Date:  2018-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.